Related Experiment Video
Updated: Aug 29, 2026

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates
Published on: September 6, 2017
[Hyperkalemia in very low birthweight infants: incidence and associated factors]
1Universidade Federal do Rio Grande do Sul.
Insights
Hyperkalemia affects 38.5% of premature infants. Higher aldosterone levels were observed in infants with hyperkalemia, but other factors were not responsible. Careful serum potassium monitoring is crucial for these newborns.
Area of Science:
- Neonatalogy
- Pediatric Nephrology
- Clinical Chemistry
Context:
- Premature infants, particularly those with very low birthweight (
- Hyperkalemia (serum potassium >or= 6 mEq/l) is a significant concern in the neonatal intensive care unit, with potential for cardiac complications.
Purpose:
- To evaluate the incidence and potential contributing factors of hyperkalemia in very low birthweight premature infants within the first 72 hours of life.
- To compare clinical and biochemical parameters between premature infants with and without hyperkalemia.
Summary:
- The study observed a 38.5% incidence of hyperkalemia in premature infants (
- Infants with hyperkalemia showed significantly lower gestational age and Apgar scores but similar birthweights compared to controls.
- Despite similar management, hyperkalemic infants had higher aldosterone levels, yet no specific factor was identified as the sole cause of non-oliguric hyperkalemia.
Impact:
- Highlights the high prevalence of hyperkalemia in a vulnerable neonatal population.
- Suggests that current management strategies may not fully prevent hyperkalemia in very low birthweight infants.
- Underscores the critical need for vigilant serum potassium monitoring and further research into the etiology of neonatal hyperkalemia.
Abstract:
The present study evaluated the incidence of hyperkalemia in premature babies born at the Hospital de Clínicas de Porto Alegre (birthweight
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Antihypertensive Drugs: Potassium-Sparing Diuretics
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
